drugset / Trial / NCT05703841
A Study of JNJ-77242113 Following Oral Administration in Healthy Chinese Adult Participants
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of the study is to assess what drug does to body when healthy Chinese participants receive single oral dose of JNJ-77242113.
Timeline
- Start
- 2023-02-14
- Primary completion
- 2023-04-07
- Completion
- 2023-04-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Icotrokinra | Peptide | — | Oral |
Indications
No indication recorded.